Found 140 clinical trials
EGFR-targeted Therapy for Gastric Cancer
Based on targeted NGS panel results, metastatic gastric cancer patients with gene amplifications will receive either anti-EGFR antibody (GC-1118) in combination with weekly paclitaxel as a
- 0 views
- 24 May, 2021
- 1 location
Intraperitoneal Docetaxel in Combination With mFOLFOX6 for Gastric Cancer Patients With Peritoneal Carcinomatosis
peritoneal carcinomatosis (GC-PC).
- 0 views
- 18 Nov, 2021
- 1 location
Fight INflammation to Improve Outcome After Aneurysmal Subarachnoid HEmorRhage (FINISHER)
contributes to DCI and therefore poor outcome and plays a major role in SAH. Some studies suggest a beneficial effect of anti-inflammatory drugs like glucocorticoids (GC) in SAH patient, but there are no
- 0 views
- 03 Jun, 2022
- 7 locations
Study on TIL for the Treatment of Advanced Breast Cancer
This study is to investigate the safety and efficacy of tumor infiltrating lymphocyte (TIL) therapy (GC 101 TIL) in patients with advanced breast cancer. Autologous TILs are expanded from tumor
- 0 views
- 04 Oct, 2022
- 1 location
MEthotrexate Versus TOcilizumab for Treatment of GIant Cell Arteritis: a Multicenter, Randomized, Controlled Trial (METOGiA)
> Glucocorticoids (GC) are the cornerstone of the treatment of GCA. They are very effective and are usually given for 18-24 months to avoid relapses. Therefore, most patients develop GC-related
- 4 views
- 30 May, 2022
- 1 location
Pharmacotoxicology of Trichloroethylene Metabolites: Kinetic Study of Dichloroacetate (DCA) in Persons Homozygous for KRT Versus Wildtype
DCA kinetics and biotransformation and 2) DCA's effects on tyrosine metabolism. Population pharmacogenetic analysis of MAAI allelic frequencies and GC or LC-MS/MS techniques for blood or
- 67 views
- 07 Nov, 2020
- 1 location
GEN-001 in Combination With Avelumab for Patients With PD-L1 Positive Gastric Cancer
which is not received the Standard of Care (SOC) for patients with PD-L1 positive advanced GC/Gastroesophageal Junction Adenocarcinoma who are not received cancer immunotherapy regimens as mono or
- 0 views
- 05 Jul, 2022
- 5 locations
Alpelisib and Paclitaxel in PIK3CA-altered Gastric Cancer
PIK3CA mutations. In addition, alpelisib inhibited cell growth via G1 arrest and subsequently induces apoptosis in GC cells, and this effect is more remarkable in cells harboring PIK3CA mutations
- 0 views
- 01 Sep, 2021
- 2 locations
PSMA-PET Imaging for Detecting Early Metastatic Prostate Cancer in Men w/ High Decipher Test Scores
American Men with Prostate Cancer: (VANDAAM)" that had high risk Decipher test results (Decipher score >0.45). Patients with a high genomic classifier (GC) score at diagnosis will be approached for
- 5 views
- 04 Oct, 2022
- 1 location
A Phase Ib/II Study of GT90001 Combined With KN046 in Solid Tumors
advanced or refractory hepatocellular carcinoma (HCC), gastric carcinoma (GC) and gastroesophageal junction (GEJ) adenocarcinoma, urothelial carcinoma (UC) and esophageal square cell carcinoma (ESCC).
- 0 views
- 18 Dec, 2021
- 1 location